Product nameAnti-TIM 1 antibody
See all TIM 1 primary antibodies
DescriptionRabbit polyclonal to TIM 1
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
A 16 amino acid peptide from near the centre of human TIM 1
- Human uterus tissue lysate.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
Storage bufferPreservative: 0.02% Sodium azide
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab47634 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 39 kDa.|
FunctionMay play a role in T-helper cell development and the regulation of asthma and allergic diseases. Receptor for TIMD4 (By similarity). In case of human hepatitis A virus (HHAV) infection, functions as a cell-surface receptor for the virus. May play a role in kidney injury and repair.
Tissue specificityWidely expressed, with highest levels in kidney and testis. Expressed by activated CD4+ T-cells during the development of helper T-cells responses.
Sequence similaritiesBelongs to the immunoglobulin superfamily. TIM family.
Contains 1 Ig-like V-type (immunoglobulin-like) domain.
- Information by UniProt
- CD365 antibody
- HAVCR 1 antibody
- HAVCR antibody
Lane 1 : Anti-TIM 1 antibody (ab47634) at 1 µg/ml
Lane 2 : Anti-TIM 1 antibody (ab47634) at 2 µg/ml
All lanes : Human uterus tissue lysate
Lysates/proteins at 15 µg per lane.
Predicted band size: 39 kDa
Observed band size: 50 kDa why is the actual band size different from the predicted?
This product has been referenced in:
- Shi B et al. Protein kinase C inhibitor chelerythrine attenuates partial unilateral ureteral obstruction induced kidney injury in neonatal rats. Life Sci 216:85-91 (2019). Read more (PubMed: 30439378) »
- Li HL et al. IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI. Oncotarget 9:36551-36560 (2018). Read more (PubMed: 30564296) »